Air India pilot at an airport terminal
An Air India pilot, who operated a flight from Phuket to Delhi that experienced a significant altitude loss, has tested positive for marijuana in a confirmatory drug test. The incident, which resulted in injuries to 17 passengers, has brought to the forefront a critical divergence in regulatory and corporate policies regarding substance abuse in the aviation sector.
The Directorate General of Civil Aviation (DGCA) permits pilots to undergo rehabilitation after a first positive test for substance abuse. However, Air India’s internal policy mandates the termination of employment for any employee testing positive for illicit substances. This discrepancy creates a challenging situation for the airline in handling such cases, balancing regulatory compliance with its own stringent safety and employment standards.
The pilot’s positive test followed an event where the aircraft rapidly lost approximately 300 feet, raising immediate concerns about operational safety. While the DGCA’s approach aims at rehabilitation and retaining skilled personnel, Air India’s stricter stance underscores a zero-tolerance policy towards substance abuse, prioritizing passenger and crew safety above all.
Further investigations are expected to clarify the sequence of events leading to the altitude loss and the pilot’s conduct. The outcome of this case could influence future policy discussions on drug testing and rehabilitation protocols within the Indian aviation industry, particularly concerning the potential impact on investment and operational standards of airlines.
About the Author
